Impact of medical checkup parameters on major adverse cardiovascular events in the general Japanese population

Tomonori Sugiura1, Hiroyuki Takase2, Yasuaki Dohi3

  • 1Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.

PubMed

Insights

Medical checkups can identify cardiovascular risk. B-type natriuretic peptide levels measured during checkups strongly predict major adverse cardiovascular events (MACE), aiding early risk identification.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Biomarker Research

Background:

  • Medical checkups are crucial for identifying individuals at high cardiovascular risk.
  • The specific impact of individual medical examination parameters on major adverse cardiovascular events (MACE) requires further investigation.
  • Understanding these predictors is vital for refining cardiovascular risk assessment strategies.

Purpose of the Study:

  • To identify predictors of MACE among parameters routinely examined during medical checkups in the general Japanese population.
  • To assess the independent predictive value of various clinical parameters for future MACE.
  • To evaluate the potential of incorporating specific biomarkers into routine checkups for enhanced cardiovascular risk stratification.

Main Methods:

  • A cohort of 13,522 individuals undergoing medical checkups between 2008 and 2015 was followed for a median of 1,827 days.
  • Major adverse cardiovascular events (MACE), including cardiovascular death, myocardial infarction, angina, heart failure, and stroke, were recorded as endpoints.
  • Multivariate Cox hazard analysis was employed to determine independent predictors of MACE after adjusting for confounders.

Main Results:

  • During follow-up, 196 participants experienced MACE.
  • Univariate analysis indicated increased MACE risk associated with hypertension, diabetes mellitus, dyslipidemia, and metabolic syndrome.
  • Multivariate analysis revealed male sex, age, systolic blood pressure, and baseline B-type natriuretic peptide (BNP) level as independent predictors of MACE, with BNP showing the most prominent impact.

Conclusions:

  • Baseline B-type natriuretic peptide (BNP) level is a strong and independent predictor of future MACE in the general population.
  • The inclusion of BNP measurement in routine medical checkups could significantly enhance the ability to identify individuals at increased cardiovascular risk.
  • Integrating BNP testing may facilitate earlier intervention and improve cardiovascular disease prevention strategies.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
727
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
158
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
812